Building Collaborative Disease Ecosystems

AiRare exists to make rare diseases visible and solvable. By uniting patients, clinicians, advocates, and pharma and biotech innovators around a shared intelligence layer, AiRare transforms real-world experience into trusted evidence that accelerates treatments, informs access, and improves outcomes - ensuring that people living with rare diseases are finally seen, supported, and served.

The Challenge

For rare diseases, fragmented care fails patients at every turn. Multi-year diagnostic delays lead to preventable progression and declining quality of life. With ~95% of rare diseases lacking approved therapies, most patients face limited treatment options beyond supportive care.

Without a unified ecosystem, 400 million people worldwide remain invisible — their data scattered, voices unheard, and needs unmet.

Our Vision

A world where rare disease patients and caregivers have agency over their own journey.

The DNA of AiRare

AiRare combines patient-facing intelligence, real-world evidence infrastructure, and advocacy-led governance to build trusted disease ecosystems.

Personal Health Navigator

Intelligence architecture, powered by disease-specific algorithms that turns real-world signals into contextualized, explainable guidance and health insights. Patients own their data and bring documented insight to every clinical encounter.

Health Insight Agent

Consented, longitudinal real-world evidence delivered on demand. The HIA draws from registry data, clinical data, PROs, wearables, and natural history models to give researchers and biopharma a single environment for population-level insight.

Coalition Model

A mission-driven governance structure that aligns all stakeholders around shared rules for how data is used, what outcomes matter, and who benefits from the intelligence created.

The AiRare Flywheel

A self-reinforcing cycle that creates compounding value for all stakeholders while ensuring sustainable social impact.

The Social Impact Index

AiRare measures success through tangible improvements in patient outcomes, care quality, and community empowerment — not just data collection.

Activation

Patients engaging weekly with the Personal Health Navigator (PHN) and guided actions

Adherence

Improved medication and follow-up adherence drives clinical eligibility and reduces crises

Quality of Life

Validated PRO improvements tied to daily symptom relief and reduced burden of disease

Outcomes

Reduction in preventable hospitalizations and ER visits - the #1 cost driver in many rare diseases

Who We Serve

Patients & Caregivers

AiRare gives patients a Personal Health Navigator that delivers proactive, personalized guidance - helping them anticipate disease progression, understand their data, and take control of their health journey.

Benefit

Personalized support that reduces uncertainty and accelerates individuals to their optimized health state by shortening time between disease journey milestones

Biopharma & Biotech

Build robust safety, outcomes, and value-evidence programs that work beyond trials to capture actual patient real-world journeys, enabling longitudinal RWD and organizing communities for therapeutic readiness.

Benefit

Real-time data access and sustained patient engagement enabling actionable cross-functional insights for better decision making across trial recruitment, real-world evidence generation, sales and marketing strategy, medical affairs, and clinical prioritization

Patient Advocacy Organizations

Access infrastructure to build disease registries, coordinate patient communities, collect patient-reported outcomes, and partner with researchers and pharma under shared governance that reinvests funds back into the community.

Benefit

Shared governance model with mission lock and community oversight that ensures value flows back to patient organizations through reinvestment of net platform proceeds

Clinical Researchers & Academic Institutions

Access high-quality, consented real-world data through federated pipelines, enabling natural history studies, biomarker research, and longitudinal cohort analysis under a collaborative governance model.

Benefit

High-quality, consented real-world data for natural history studies and biomarker research with robust governance framework

Healthcare Providers & Health Systems

Gain unified patient insights and early-warning signals that improve care coordination, outcome tracking, and population health management for rare disease patients.

Benefit

Unified patient insights and early-warning signals that support care coordination and outcome tracking

Payers & Public Health Systems

Access early-warning intelligence and coordinated population insights that reduce high-cost utilization, prevent avoidable admissions, and support value-based care models for rare diseases.

Benefit

Reduced high-cost utilization and preventable admissions through predictive intelligence and coordinated care

Building Collaborative Disease Ecosystems

The Challenge

Our Vision

The DNA of AiRare

Personal Health Navigator

Health Insight Agent

Coalition Model

The AiRare Flywheel

The Social Impact Index

Activation

Adherence

Quality of Life

Outcomes

Who We Serve

Patients & Caregivers

Benefit

Biopharma & Biotech

Benefit

Patient Advocacy Organizations

Benefit

Clinical Researchers & Academic Institutions

Benefit

Healthcare Providers & Health Systems

Benefit

Payers & Public Health Systems

Benefit

Let’s work

together